Antimicrobial Resistance Action Fund will infuse US$1 billion into search for new antibiotics

A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030.